Contrary to GBM, in pituitary tumors, immunohistochemistry analysis of MGMT has been frequently used, and tumors with low MGMT immunoexpression have generally had a better response to treatment (39, 76, 77, 93). The gene discussed is MGMT; the disease is pituitary tumor.